Ignalinos sveikatos centras - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 701,534 | 872,393 | 1,009,352 | 1,233,737 | 1,402,026 | 1,588,445 | 1,739,877 | 1,887,255 |
| Profit before tax | 44,234 | 72,941 | 96,006 | 104,217 | 172,320 | 148,416 | 135,069 | 170,652 |
| Net profit | 44,056 | 72,676 | 94,665 | 102,730 | 171,179 | 146,440 | 132,625 | 143,144 |
| Equity | -58,248 | 14,428 | 109,093 | 119,807 | 220,986 | 257,426 | 290,051 | 313,195 |
| Liabilities | 160,569 | 97,628 | 43,344 | 51,133 | 56,768 | 69,448 | 74,245 | 109,163 |
| Non-current assets | 4,565 | 54,256 | 42,557 | 30,206 | 17,516 | 43,108 | 38,211 | 55,837 |
| Current assets | 96,863 | 105,919 | 146,133 | 165,128 | 273,179 | 288,270 | 338,559 | 366,353 |
| Total assets | 101,428 | 160,175 | 188,690 | 195,334 | 290,695 | 331,378 | 376,770 | 422,190 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 222,596 | 244,080 | 270,581 |
| Social insurance contributions | - | - | - | - | - | 253,394 | 279,859 | 303,372 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +15.9% | +24.4% | +15.7% | +22.2% | +13.6% | +13.3% | +9.5% | +8.5% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 43.4% | 45.4% | 50.2% | 52.6% | 58.9% | 44.2% | 35.2% | 33.9% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | - | 503.7% | 86.8% | 85.7% | 77.5% | 56.9% | 45.7% | 45.7% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 6.3% | 8.3% | 9.4% | 8.3% | 12.2% | 9.2% | 7.6% | 7.6% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 6.3% | 8.4% | 9.5% | 8.4% | 12.3% | 9.3% | 7.8% | 9.0% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | 6.8 | 0.4 | 0.4 | 0.3 | 0.3 | 0.3 | 0.3 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 18,918 | 22,660 | 26,446 | 29,492 | 32,169 | 33,500 | 38,521 | 41,939 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Ignalinos sveikatos centras - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2025-04-16 | 2025-04-21 | 4503.41 |
| 2023-03-16 | 2023-03-19 | 63.42 |
| 2023-02-17 | 2023-02-20 | 62.62 |
| 2022-09-16 | 2022-09-19 | 77.97 |
| 2021-12-16 | 2022-01-02 | 1.25 |
Ignalinos sveikatos centras - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2026-04-30 | 2026-05-07 | 74.1 |
| 2026-02-21 | 2026-02-21 | 2.12 |
| 2026-01-20 | 2026-01-27 | 2.12 |
| 2026-01-08 | 2026-01-19 | 204.39 |
| 2025-07-12 | 2025-08-18 | 1.46 |
| 2025-07-10 | 2025-07-11 | 7.67 |
| 2025-06-18 | 2025-07-09 | 1.46 |
| 2025-02-20 | 2025-04-25 | 1.46 |
| 2024-12-11 | 2025-01-30 | 1.46 |
| 2024-12-08 | 2024-12-10 | 146.27 |
| 2024-12-07 | 2024-12-07 | 146.15 |
| 2024-09-11 | 2024-12-06 | 1.46 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Ignalinos sveikatos centras, UAB (code 301358544) is a Private Limited Liability Company engaged in general medical practice activities. In 2025, the company generated revenue of €1.89M, up 8.5% year on year and 18.8% over two years. Net profit reached €143.1K, broadly in line with 2024 and above the €146.4K reported in 2023, while the profit margin remained stable at 7.6% in 2024 and 2025 after 9.2% in 2023. The revenue trend shows steady growth from €1.59M in 2023 to €1.74M in 2024 and €1.89M in 2025, indicating consistent expansion with moderate margin pressure versus 2023. The balance sheet also strengthened: total assets increased from €331.4K in 2023 to €376.8K in 2024 and €422.2K in 2025, while equity rose to €313.2K and liabilities to €109.2K in 2025. The equity ratio was 74.2%, debt-to-equity 0.35, asset turnover 4.47x, ROE 45.7% and ROA 33.9%. Revenue per employee was €41.9K, with profit per employee at €3.2K.